NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,825 | -1.1% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,904 | +0.5% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,872 | +13.1% | 67 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,078 | +21.6% | 67 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -16.7% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | 0.0% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | +100.0% | 67 | +67.5% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | -66.7% | 40 | -60.0% | 0.00% | -66.7% |
| Q4 2017 | $9,000 | -79.1% | 100 | -80.0% | 0.01% | -79.3% |
| Q3 2017 | $43,000 | +2.4% | 500 | 0.0% | 0.03% | +3.6% |
| Q2 2017 | $42,000 | +90.9% | 500 | +66.7% | 0.03% | +75.0% |
| Q1 2017 | $22,000 | 0.0% | 300 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $22,000 | – | 300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 335,936 | $29,213,000 | 5.81% |
| Martin Investment Management, LLC | 170,759 | $14,849,000 | 5.36% |
| Mawer Investment Management Ltd. | 8,515,391 | $740,498,000 | 4.84% |
| SCHARF INVESTMENTS, LLC | 1,212,354 | $105,426,000 | 4.54% |
| Hansberger Growth Investors, LP | 45,645 | $3,969,000 | 4.50% |
| GARLAND CAPITAL MANAGEMENT INC | 50,905 | $4,427,000 | 3.95% |
| First Fiduciary Investment Counsel, Inc. | 193,021 | $16,785,000 | 3.49% |
| PROFESSIONAL ADVISORY SERVICES INC | 224,087 | $19,487,000 | 3.48% |
| WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC | 362,047 | $31,484,000 | 3.29% |
| WILKINS INVESTMENT COUNSEL INC | 126,470 | $10,998,000 | 3.28% |